Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Sylvie, Kirscher"'
Autor:
Anne-Laure Couderc, Emilie Nouguerède, Karine Baumstarck, Sandrine Loubière, Hervé Le Caer, Olivier Guillem, Frédérique Rousseau, Laurent Greillier, Emmanuelle Norguet-Monnereau, Maud Cecile, Rabia Boulahssass, Françoise Le Caer, Sandrine Tournier, Chantal Butaud, Pierre Guillet, Sophie Nahon, Sylvie Kirscher, Nadine Diaz, Claire Morando, Patrick Villani, Pascal Auquier, Aurélie Daumas
Publikováno v:
Trials, Vol 20, Iss 1, Pp 1-4 (2019)
Abstract Background Social isolation potentiates the risk of death by cancer in the older cancer patient population. The PREDOMOS study investigates the impact of establishing a Program of Social intervention associated with techniques of Domotic and
Externí odkaz:
https://doaj.org/article/91b2236af04440dcabfea5cd04311774
Autor:
Elodie Crétel-Durand, Emilie Nouguerède, Hervé Le Caer, Frédérique Rousseau, Frédérique Retornaz, Olivier Guillem, Anne-Laure Couderc, Laurent Greillier, Emmanuelle Norguet, Maud Cécile, Rabia Boulahssass, Francoise Le Caer, Sandrine Tournier, Chantal Butaud, Pierre Guillet, Sophie Nahon, Laure Poudens, Sylvie Kirscher, Sandrine Loubière, Nadine Diaz, Jean Dhorne, Pascal Auquier, Karine Baumstarck
Publikováno v:
Trials, Vol 18, Iss 1, Pp 1-11 (2017)
Abstract Background Cancer incidence and social isolation increase along with advanced age, and social isolation potentiates the relative risk of death by cancer. Once spotted, social isolation can be averted with the intervention of a multidisciplin
Externí odkaz:
https://doaj.org/article/2fc94308d89b4256a2bdc0d73b278a48
Autor:
Rania Boustany, Antoine Arnaud, Philippe Debourdeau, Léa Vazquez, Sylvie Kirscher, Gaëtan de Rauglaudre, A. Mège, J. Grenier
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 29(7)
Metastatic breast cancer (MBC) patients experience long survival and report poorer quality of life than localized breast cancer patients. Comprehensive supportive care (CSC) has been shown to improve the quality of life (QoL) of MBC. The respective p
Autor:
Gaëtan de Rauglaudre, Samy Khouri, L. Mineur, D. Serin, Isabelle Sant, Sylvie Kirscher, Philippe Debourdeau, Françoise Blanc-Legier, Grégory Ninot, Isabelle Piollet, Françoise De Crozals, Pierre Schillinger
Publikováno v:
Bulletin du Cancer
Bulletin du Cancer, John Libbey Eurotext, 2018, 105 (9), pp.763-770. ⟨10.1016/j.bulcan.2018.04.007⟩
Bulletin du Cancer, John Libbey Eurotext, 2018, 105 (9), pp.763-770. ⟨10.1016/j.bulcan.2018.04.007⟩
Autre titre : Supportive care for survivors; International audience; Les progrès dans le dépistage précoce et les thérapeutiques ont fait basculer en quelques décennies la prise en charge de cancers d’un modèle de préparation optimale à la
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa896f04236c27bff4a084d27a5b962f
https://hal.archives-ouvertes.fr/hal-03063601
https://hal.archives-ouvertes.fr/hal-03063601
Autor:
Frédérique Retornaz, Karine Baumstarck, Laurent Greillier, Sylvie Kirscher, Sophie Nahon, Sandrine Loubière, Laure Poudens, Chantal Butaud, Emmanuelle Norguet, Rabia Boulahssass, Anne-Laure Couderc, Pascal Auquier, Emilie Nouguerède, Francoise Le Caer, Sandrine Tournier, Pierre Guillet, Hervé Le Caer, Frédérique Rousseau, Jean Dhorne, Maud Cécile, Nadine Diaz, Olivier Guillem, Elodie Crétel-Durand
Publikováno v:
Trials
Trials, Vol 18, Iss 1, Pp 1-11 (2017)
Trials, Vol 18, Iss 1, Pp 1-11 (2017)
Background Cancer incidence and social isolation increase along with advanced age, and social isolation potentiates the relative risk of death by cancer. Once spotted, social isolation can be averted with the intervention of a multidisciplinary team.
Autor:
Philippe Debourdeau, Celeste David, Antoine Arnaud, Marion Velensek, Yvelise Goubely, Gaëtan de Rauglaudre, Léa Vazquez, Rania Boustany, Julien Grenier, A. Mège, Sylvie Kirscher
Publikováno v:
The Breast. 48:S65
Autor:
Grégory, Ninot, Philippe, Debourdeau, Françoise, Blanc-Legier, Françoise, De Crozals, Gaétan, De Rauglaudre, Samy, Khouri, Sylvie, Kirscher, Laurent, Mineur, Isabelle, Piollet, Isabelle, Sant, Pierre, Schillinger, Daniel, Serin
Publikováno v:
Bulletin du cancer. 105(9)
Advances in early detection and treatment have pushed in a few decades the management of cancers from a management model of the end of life to the management of a chronic disease. This evolution has accelerated the development of supportive care in t
Autor:
Emmanuelle Bourbouloux, Sophie Abadie, Lionel Uwer, Brigitte Laguerre, Emmanuelle Fourme, Sylvia Luneau, Emmanuel Blot, Jean Genève, Marc Debled, C. Mertens, Frédérique Rousseau, Etienne Brain, Sylvie Kirscher, Véronique Girre, Loic Mourey, Isabelle Van Praagh-Doreau
Publikováno v:
Critical reviews in oncology/hematology. 80(1)
Breast cancer is a disease of ageing. Functional independence in elderly patients, measured with the Katz activities of daily living (ADL) scale, predicts overall survival and the need for welfare support. Few prospective studies have examined the fe
Autor:
Farid El Hajbi, Faiza Khemissa, Sylvie Kirscher, Christophe Locher, Dominique Genet, Julien Taieb, Thomas Aparicio, Yves Rinaldi, Pierre-Luc Etienne, Thierry Lecomte, Roger Faroux, Olivier Bouché, Laurent Bedenne, Alice Oden-Gangloff, Elena Paillaud, M. Baconnier, Emilie Maillard, Sandrine Lavau-Denes, Eric Francois, Frederic Retornaz
Publikováno v:
Journal of Clinical Oncology. 33:3541-3541
3541 Background: AVEX study has demonstrated increased progression-free survival (PFS) with capecitabine + bevacizumab compared to capecitabine alone in pts aged over 70 with mCRC. The treatment wi...
Autor:
E. Malaurie, Christine Orsini, Nicole Tubiana-Mathieu, Claudia Lefeuvre, D. Allouache, Emmanuelle Bourbouloux, Franck Bonnetain, Florence Rollot, Hervé Curé, Emmanuel Blot, Paul Cottu, Jean-Marc Ferrero, Olivier Mir, Etienne Brain, Sylvie Kirscher, Coraline Dubot, Gilles Romieu, Olivier Rigal, Magali Lacroix-Triki, Hélène Peyro-Saint-Paul
Publikováno v:
Cancer Research. 75:OT3-3
The benefit of adjuvant chemotherapy (CT) added to hormonal therapy (HT) compared with HT alone remains debated for women >70 with ER+ HER2- breast cancer (BC). Selection of valid indications might be improved by the use of better prognosticator. Thi